Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

Share Price is delayed by 15 minutes
Get Live Data
218.50    -0.50 (-0.23%)
Bid:
218.50
Ask:
219.50
Spread: 1.00 (0.458%)
Market Cap: £474.65m
AMS Live PriceLast checked at - London Stock Exchange

Intraday Advanced Medical Solutions Group Share Chart

Director/PDMR Shareholding

1 May 2014 14:32

RNS Number : 0951G
Advanced Medical Solutions Grp PLC
01 May 2014
 



1 May 2014

Advanced Medical Solutions Group plc ("AMS" or the "Company")

Directors' shareholdings

Advanced Medical Solutions Group plc (AIM:AMS), the global medical technology company, today announces that the following Directors purchased ordinary shares of 5 pence each ("Ordinary Shares") on 30 April 2014, as part of the Deferred Share Bonus Plan. These Ordinary Shares were bought at a price of 126 pence per share and, under the terms of the Plan, will be held in trust on their behalf.

Following these transactions the beneficial ownership of Chris Meredith and Mary Tavener is as follows:

Director

Date purchased

Shares Purchased

Resultant Holding

% of issued share capital

Chris Meredith, Chief Executive Officer

 

30 April 2014

2,269

1,185,207

0.6

Mary Tavener, Group Finance Director

 

30 April 2014

1,428

1,774,470

0.9

 

For further information:

Advanced Medical Solutions Group plc

Mary Tavener, Group Finance Director +44 (0) 1606 545 508

Investec (NOMAD)

Daniel Adams +44 (0) 20 7597 5970

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBXGDUBXGBGSB
Date   Source Headline
6th Mar 20199:13 amRNSBlock listing Interim Review
4th Mar 20192:24 pmRNSHolding(s) in Company
19th Feb 20197:00 amRNSNotice of Results
12th Feb 20194:23 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSAcquisition of Sealantis
31st Dec 20187:00 amRNSManagement Change
31st Dec 20187:00 amRNSTotal Voting Rights
20th Dec 20187:00 amRNSFix8 approved in Europe
18th Dec 20187:00 amRNSTrading Update
30th Nov 20181:40 pmRNSTotal Voting Rights
9th Nov 20183:06 pmRNSHoldings in Company
6th Nov 20184:33 pmRNSApplication for Admission
2nd Nov 201811:13 amRNSHolding(s) in Company
31st Oct 20185:20 pmRNSTotal Voting Rights
17th Sep 20184:30 pmRNSHolding(s) in Company
12th Sep 20187:00 amRNSInterim Results
31st Aug 20184:08 pmRNSApplication for Admission
10th Aug 20187:00 amRNSFDA approval for two woundcare portfolio dressings
7th Aug 20185:22 pmRNSHoldings in Company
27th Jul 20187:00 amRNSNotice of Interim Results
26th Jul 20183:23 pmRNSHoldings in Company
25th Jul 20182:26 pmRNSHoldings in Company
18th Jul 201812:28 pmRNSHolding(s) in Company
5th Jul 20187:00 amRNSTrading Update
29th Jun 20183:42 pmRNSTotal Voting Rights
28th Jun 20184:36 pmRNSDirector/PDMR Shareholding
11th Jun 20185:12 pmRNSDirector/PDMR Shareholding
6th Jun 201812:15 pmRNSResult of AGM
6th Jun 20187:00 amRNSNotice of AGM and Management Change
31st May 20183:49 pmRNSTotal Voting Rights
3rd May 20186:29 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20185:12 pmRNSDirector/PDMR and PCA Shareholding
3rd May 201812:27 pmRNSDirector Declaration
30th Apr 20185:02 pmRNSTotal Voting Rights
26th Apr 20187:00 amRNSNotice of Annual General Meeting and Annual Report
18th Apr 20189:45 amRNSDirector/PDMR and PCA Shareholding
5th Apr 20185:46 pmRNSDirector/PDMR Shareholding
14th Mar 20187:00 amRNSUnaudited preliminary results
9th Feb 20187:00 amRNSNotice of Results
29th Dec 20177:00 amRNSTotal Voting Rights
14th Dec 20177:00 amRNSPre-Close Trading Update
30th Nov 20175:28 pmRNSTotal Voting Rights
30th Nov 20173:54 pmRNSDirector/PDMR Shareholding
21st Nov 20176:16 pmRNSHolding(s) in Company
6th Nov 201710:45 amRNSPDMR Shareholding
31st Oct 20175:16 pmRNSTotal Voting Rights
31st Oct 20175:15 pmRNSHoldings in Company
26th Oct 20177:00 amRNSPatent Out-licensing Agreement
20th Sep 20175:04 pmRNSHolding(s) in Company
13th Sep 20177:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.